Litcius/Paper detail

Meta-analyses on progression-free survival as a surrogate endpoint for overall survival in triple-negative breast cancer

Takehiro Hirai, Asuka Nemoto, Yoshinori Ito, Masaaki Matsuura

2020Breast Cancer Research and Treatment22 citationsDOI

Topics & Concepts

MedicineInternal medicineBreast cancerBevacizumabSurrogate endpointOncologyClinical endpointTriple-negative breast cancerConfidence intervalMetastatic breast cancerProgression-free survivalCancerCorrelationClinical trialOverall survivalChemotherapyGeometryMathematicsCancer Treatment and PharmacologyBreast Cancer Treatment StudiesPARP inhibition in cancer therapy
Meta-analyses on progression-free survival as a surrogate endpoint for overall survival in triple-negative breast cancer | Litcius